HOME >> MEDICINE >> NEWS
Longest ever follow-up study of a targeted cancer therapy shows excellent results

ATLANTA, Ga. - The overall survival of most people with chronic myelogenous leukemia (CML) treated with imatinib (Gleevec, STI-571) is extremely high and the relapse rate is quite low, according to new data from a study out of the Oregon Health & Science University Cancer Institute. The overall survival at five years is 89 percent as compared to no more than 50 percent with prior therapies, and the risk of relapse continues to decrease the longer patients take the drug.

"This represents a complete turn around in the prognosis for patients with this disease," said Brian J. Druker, M.D., who originally collaborated with Novartis scientists to develop Gleevec into a successful treatment for CML. He is the JELD-WEN chair of leukemia research in the OHSU Cancer Institute and an investigator of the Howard Hughes Medical Institute.

Druker presented the five-year update from the IRIS (International Randomized IFN vs. ST1571) Study Group on Saturday, June 3 at the 2006 annual meeting of the American Society of Clinical Oncology in Atlanta, Ga.

Begun in June 2000, the phase III trial involved 1,106 subjects at 117 centers in 16 countries. Subjects were in CML's chronic phase, the most common stage of the disease, and had not previously received chemotherapy. Half were randomized to receive Gleevec and half to receive the standard treatment at the time the trial started, interferon-alpha and cytarabine arabinoside. Participants in the interferon arm were later allowed to cross over to Gleevec. Just 3 percent remain on interferon therapy.

"Prior to this, we had to project what the five-year survival data would be and worried that the risk of relapse might increase. With this data, we have increased confidence in this targeted therapy," Druker said.

At five years, the overall survival of the 553 subjects randomized to receive Gleevec as their initial therapy was 89 percent; 95 percent if only deaths related to CML are con
'"/>

Contact: Rachel MacKnight
macknigh@ohsu.edu
503-494-8231
Oregon Health & Science University
3-Jun-2006


Page: 1 2

Related medicine news :

1. Regular follow-up important during antidepressant treatment
2. UCLA/VA study: Many patients not receiving follow-up tests after positive screening for colon cancer
3. Short term follow-up proves to be helpful
4. St. Jude develops more affordable ALL follow-up test
5. Physician counseling, at-home follow-up may improve teen health behaviors
6. Accentia Biopharmaceuticals announces that follow-up data
7. Tamoxifen reduces risk of breast cancer, follow-up study confirms
8. Single-visit program for cervical cancer screening increases rate of follow-up, treatment
9. Preliminary data update from Betaseron 16 yr. long-term follow-up study in patients with MS
10. Insurance status affects ability to secure necessary, timely follow-up medical appointments
11. Children with high blood lead levels often do not receive follow-up tests

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2020)... ... August 31, 2020 , ... Smile Brands Inc., ... in the United States, today announced the grand opening of another affiliated ... Patients will enjoy convenient hours, a comfortable office, and full-service care at the ...
(Date:8/31/2020)... ... August 31, 2020 , ... Dr. Chang has over 20 ... and other developmental disabilities, as well as supporting staff in caring for patients ... school consultation, and staff development. She joined the company in 2015 as Chief ...
(Date:8/28/2020)... ... August 28, 2020 , ... ... designed to help treat patients with respiratory conditions, including COVID-19, while reducing the ... and oxygen, but it captures exhaled gas and scrubs it free of carbon ...
(Date:8/28/2020)... ... 28, 2020 , ... Ziegler, a specialty investment bank, is ... Synchronous Health, a tech-enabled behavioral health and well-being solutions provider. , Synchronous ... artificial intelligence (AI) to increase access and quality of behavioral health services, and ...
(Date:8/27/2020)... MORRISTOWN, N.J. (PRWEB) , ... August 27, 2020 ... ... has continued to partner with Evolution Labs to provide their students with Suite360:Mental ... issues related to Mental Health, Substance Abuse and Child Trafficking Prevention. , Florida ...
Breaking Medicine News(10 mins):
(Date:9/1/2020)... ... September 01, 2020 , ... September is National Ovarian Cancer Awareness Month. ... any other cancer of the female reproductive system. The American Cancer Society estimates ... 14,000 women will die from this disease. Throughout the month of September, Women’s ...
(Date:8/31/2020)... ... 31, 2020 , ... Continuing on its rapid national expansion ... and deodorization provider - is proud to announce it has opened doors in ... and residents throughout the area. , Germinator provides a 100% safe and non-toxic ...
(Date:8/28/2020)... ANGELES (PRWEB) , ... August 28, 2020 , ... ... board-certified reproductive and endoscopic surgeon and serves as a clinical professor in the Department ... President of the American Laparoscopy Society & Pacific Coast Reproductive Society and is a ...
Breaking Medicine Technology:
Cached News: